eFax (for Android)

One would think that e-mail, FTP, instant messaging, and other methods of transferring files would have killed the fax machine, but the antiquated tool is still alive and kicking, especially in the business sector. Fortunately, you no longer need a dedicated fax machine (and the associated phone line and ink) to send and receive paperwork. eFax (Various prices 4 stars), an Internet-based fax service available in over 3,500 cities and 46 countries worldwide, gives you a real fax number that you can use to send and receive faxes?using your smartphone. The electronic faxing service's new Android app keeps most of the desktop version's functionality by letting the business-minded send messages from their Google-powered smartphones. ?You may not be able to apply digital signatures as you can with the desktop version, but it's a competent and capable business-friendly mobile app.

Simple Setup
eFax' Android app has a simple set up process for those who are new to the service. You simply input your name, email address, area code, phone number, check the Customer Agreement box, and tap Start Faxing. I inputted it into the app so that I could log in after receiving the fax number and pin in an email. I then arrived at the home screen that featured four main sections: "View Inbox," "View Folders," "Search Faxes," and "Send A Fax." Each section's function is self-explanatory. Naturally, existing eFax users can simply log in with their credentials.

Cost
There are three different types of eFax accounts: Free, Plus, and Pro. The free account lets you receive (not send) just 10 faxes per month, so it's a good match for those who very rarely fax. Next up the ladder is eFax Plus ($16.95 per month), which includes 130 pages of incoming faxes, and a 15-cent per page coverage fee (there's also a $10 one-time set up charge). eFax also offers a Pro model ($19.95 per month, $220 per year) designed for large businesses and individuals with heavy faxing needs. There's a $19.95 one-time set up fee, but with the higher cost comes 200 pages of incoming faxes and a cool voicemail feature that sends left messages to your inbox. There's also a 10-cent per page overage charge, which is five cents cheaper than the basic plan.

The Plus and Pro accounts are relatively expensive compared to Send2Fax' Home Office and Small Business plans which are $8.95 per month and $12.95 per month, respectively. MyFax has three plans, one of which starts of $10 per month for 100 faxes sent and 200 received.

The eFax Experience
Firing off a fax required that I tap "Send A Fax," key a phone number into the address field, and optionally fill in cover letter information. At the moment, eFax for Android only allows you to send photos snapped with the phone's camera or stored within the image gallery?no other file types. So, if you want to send a document, you'd have to shoot it with your phone's camera and then send it (which is what I did to test the service). You can, however, use eFax' email-to-fax capabilities (outside of the mobile app) to send files of any type.

The recipient contacted me stating that he received the fax five minutes after it was sent. When he responded with a fax of his own, it arrived in my inbox seven minutes later?not bad considering the money I saved on a dedicated machine, ink, and paper. Faxes can be tagged and archived, or forwarded as faxes or email messages, but you can?t add digital signatures as you can with the desktop version. Note: Fax quality may vary depending on your phone's camera.

Should You Subscribe to eFax?
eFax for Android works because it makes the fax process simple?you don't need to own a machine or visit Kinkos. All that's needed is a Web connection, which means you can fax from nearly any location. eFax for Android may only let you fax photos , and it doesn't support digital signatures, but there's an extremely high convenience factor. All in all, eFax is a solid companion for the for business customers who want to save on paper and ink.

More Android Apps Reviews:
??? eFax (for Android)
??? McAfee Family Protection Android Edition
??? OnLive (for Android)
??? LogMeIn Ignition (for Android)
??? Google Android 4.0 "Ice Cream Sandwich"
?? more

Source: http://feedproxy.google.com/~r/ziffdavis/pcmag/~3/ciuNnaHSAiQ/0,2817,2397975,00.asp

how to make it in america how to make it in america schweddy balls schweddy balls hedy lamarr bill conlin clippers

Rome meeting analyses Iran oil embargo (Reuters)

ROME (Reuters) ? Diplomats from a so-called "group of like-minded nations" met in Rome on Tuesday to discuss further sanctions against Iran, diplomatic sources said.

The closed-door meeting is taking place under the auspices of the Italian foreign ministry and participants considered it a "technical meeting," an Italian diplomatic source said.

Diplomats said it would consider the arguments around a possible EU oil embargo against Iran. A decision may be made when EU foreign ministers next meet in January.

No decisions are expected to emerge from Tuesday's meeting.

Participants are countries that have imposed bilateral sanctions on Iran over its nuclear program that go beyond U.N. Security Council sanctions.

The group includes the United States, the European Union and several European nations, Australia, Japan, South Korea and other countries but it was not clear if all of them were represented. The United States is attending.

The small informal group has been meeting for two years and its goal is to share information and discuss the next steps in the sanctions process.

The United States has long banned Iranian crude imports and last week Congress voted through restrictions on dealing with the Iranian central bank. The White House must decide whether or not to grant waivers to major Iranian oil importers like China, India and South Korea that need to deal with the bank to pay for Iran's crude.

(Reporting By Philip Pullella, additional reporting by Roberto Landucci in Rome)

Source: http://us.rd.yahoo.com/dailynews/rss/iran/*http%3A//news.yahoo.com/s/nm/20111220/wl_nm/us_iran_sanctions_meeting

personhood amendment haynesworth haynesworth ohio issue 2 ohio issue 2 mississippi personhood mississippi personhood

Talks about forgiving Greek debt proving difficult (AP)

BRUSSELS ? Private creditors are balking in talks about forgiving euro100 billion ($130 billion) in Greek debts, European officials warned Friday, just as negotiations heated up on the debt restructuring that aims to save Athens from bankruptcy.

European and Greek negotiators met with representatives from banks and investment funds Friday in Paris, after holding talks earlier this week in Athens.

They were trying to work out the terms under which private creditors are willing to exchange their existing Greek bonds for new ones with a lower face value.

The swap, which was meant to go ahead in early 2012, is supposed to reduce Greece's debt to 120 percent of gross domestic product by 2020. Without a restructuring, Greece's debt load would reach almost 200 percent of GDP by the end of 2012.

The concept behind the debt forgiveness is that getting back half of one's investment is better than the much bigger losses bondholders would likely face if Greece defaults. A deal with private creditors to share the burden of digging Greece out of its financial hole is key to a second, euro130 billion ($169 billion) bailout for Greece from the International Monetary Fund and other eurozone countries.

But some investors had taken out insurance on their Greek bond holdings, and if they voluntarily agree to the swap, they will not receive the insurance payments they would have if Greece had just defaulted. Others, who may have bought the bonds at already depressed prices, may be willing to take a gamble in the negotiations and try for a bigger payout.

"They are not making it easy, to say the least. It will take time," said one European official. "They are trying to reopen things" that were already considered decided, the official added, without providing details.

A second European official confirmed that a final deal on the debt relief was still elusive. Both spoke on condition of anonymity because the talks are going on behind closed doors.

The cautioning words from the two officials came as Greek Finance Minister Venizelos told the Greek parliament he was confident the debt writedown would go ahead.

"I believe we will achieve that because I have positive signs from the consultations and the course of the discussions," Venizelos said Friday. "That would offer the Greek people ... a return for its sacrifices and a prospect for younger generations."

The 17 nations that use the euro and bank representatives reached a deal to reduce Greece's debts in late October after determining that the struggling country would not be able to repay them in full.

However, the Institute for International Finance, which has been leading the negotiations, has insisted that actual losses for investors have to be kept as low as possible for them to agree to participate voluntarily.

To keep overall losses under control, private creditors are pushing for higher interest rates from Greece and expensive collateral to secure the new bonds. That, in turn, could eliminate much of the benefits to Greece of a cut in the bonds' face value. Of the euro130 billion in the second bailout for Greece, euro30 billion ($39 billion) is meant to provide collateral for the bond swap.

In a statement following Friday's talks, the IIF said "the private sector welcomed the willingness of the authorities to work on means to enhance the quality of the exchanged debt" ? shorthand for the collateral provisions.

It said the talks had made progress "and both sides agreed to continue their effort to find a voluntary solution that would help put Greece on a path of debt sustainability and economic recovery."

__

Nicholas Paphitis in Athens contributed to this story.

Source: http://us.rd.yahoo.com/dailynews/rss/eurobiz/*http%3A//news.yahoo.com/s/ap/20111216/ap_on_bi_ge/eu_greece_financial_crisis

leftover turkey recipes hugo hugo the muppets percy harvin percy harvin best cyber monday deals

Shutup, Twitter Isn't Censoring Your Dumb Trends [Twitter]

So brilliant writer and Iraq War apologist Christopher Hitchens died last night. Almost immediately, #GodIsNotGreat started trending on Twitter. It's the title of one of Hitchens' books, of course, but it made a lot of people angry. More »

Source: http://feeds.gawker.com/~r/gizmodo/full/~3/0wcmpbKacQE/shutup-twitter-isnt-censoring-your-dumb-trends

dash diet weather phoenix dippin dots triumph the insult comic dog tucson weather tucson weather peyton hillis

Senate passes two-month extension of Social Security tax cut, additional unemployment benefits (Star Tribune)

Share With Friends: | | Politics - Top Stories Stories, RSS and RSS Feed via Feedzilla.

Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/175890166?client_source=feed&format=rss

lindsay lohan’s playboy cover leaked online lindsay lohan’s playboy cover leaked online kevin martin va tech shooting 2011 cj wilson coriolanus coriolanus

Childhood cancer drugs cure now, may cause problems later, research shows

ScienceDaily (Dec. 16, 2011) ? Will a drug used to treat childhood acute lymphoblastic leukemia and other pediatric cancers cause heart problems later in life?

UB associate professor of pharmaceutical sciences, Javier G. Blanco, PhD, who sees his work as a bridge between research and clinical practice, has focused recent efforts on trying to answer this question.

Blanco and colleagues' recent study in the Journal of Clinical Oncology looked for the underlying genetic answers to why some childhood cancer survivors who were treated with anthracylines -- powerful antibiotics like Adriamycin and Daunomycin -- developed cardiomyopathy, such as congestive heart failure, later in life.

"Anthracyclines are effective drugs used to treat a variety of pediatric cancers, they are also used to treat breast cancer and other malignancies in adults," Blanco says. "After cancer, survivors can develop cardiac toxicity anywhere from one year to more than 15 years after the initial chemotherapy with anthracyclines. The window separating the effectiveness of these drugs from their toxicity is narrow. The dosage has to be precise to achieve a therapeutic effect without toxicity."

Blanco explains that the key to individualizing any drug treatment comes down to understanding the way an individual is genetically coded to respond to the drug once it enters the body, and then adjusting the dose accordingly.

Working closely with Smita Bhatia, MD, MPH, chair of the Department of Population Sciences at City of Hope National Medical Center in California and senior author of the study, Blanco and a team of researchers decided to look at how the drug was broken down by enzymes encoded by specific genes.

The study, which began seven years ago, compared DNA genotypes of 170 childhood cancer survivors diagnosed with anthracycline-related cardiomyopathy to a control group of 317 survivors without heart disease.

Using the candidate gene approach, Blanco and his team were able to identify a tiny gene variant related to the risk of cardiotoxicity.

"We pinpointed the genetic difference or polymorphism that makes an enzyme work faster or slower in patients," said Blanco, "slower is better."

They zeroed-in on carbonyl reductases (CBR1 and CBR3) -- two enzymes that break down anthracyclines into cardiotoxic alcohol metabolites. Blanco notes that in mouse models, higher levels of CBRs or faster enzymes dictate higher levels of these metabolites -- and more cardio toxicity.

The research showed that the risk of cardiomyopathy was significantly increased among individuals with two copies of the "G" version of the CBR3 polymorphism when exposed to low-to-moderate doses of anthracycline.

Blanco says that while the results of the study validated the findings of an earlier study in a totally independent cohort of cancer survivors, further study is required.

"We have to be careful," says Blanco. "So far, we are showing an association, not yet causation. Our next step will be to conduct a prospective study -- where we don't study individuals who were exposed to anthracyclines in the past but follow them in real time as they are receiving the drug and after."

What does this mean for children who are taking or have taken anthracyclines?

"If we stop using anthracyclines we will not be able to cure up to 90 percent of the children who suffer from acute lymphoblastic leukemia." Blanco says. "Parents must continue to have their children's health monitored long after the cancer is cured to identify cardiac problems if they develop."

Blanco's research is primarily funded by the National Institute of General Medical Sciences (NIGMS), the Lance Armstrong Foundation and the Leukemia and Lymphoma Society, among many others.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

---

Story Source:

The above story is reprinted from materials provided by University at Buffalo.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

---

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://www.sciencedaily.com/releases/2011/12/111216175244.htm

apple juice jay cutler carole king katharine mcphee neil diamond miranda kerr occupy la

Gingrich faces shouting protesters in Iowa (The Arizona Republic)

Share With Friends: | | Politics - Top Stories News, RSS Feeds and Widgets via Feedzilla.

Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/174845477?client_source=feed&format=rss

patsy cline packers stock sale packers stock sale broncos broncos jason mayhem miller denver broncos